Amsterdam UMC, Department of Internal Medicine, Section of Geriatric Medicine, University of Amsterdam, Amsterdam, The Netherlands.
Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
Eur Geriatr Med. 2023 Aug;14(4):649-658. doi: 10.1007/s41999-023-00824-8. Epub 2023 Jul 15.
Falls prevention and management in older adults is a critical global challenge. One of the key risk factors for falls is the use of certain medications. Therefore, to prevent medication-related falls, the following is recommended in the recent World Guidelines for Falls Prevention and Management: (1) assess for fall history and the risk of falls before prescribing potential fall-risk-increasing drugs (FRIDs), (2) use a validated, structured screening and assessment tool to identify FRIDs when performing a medication review, (3) include medication review and appropriate deprescribing of FRIDs as a part of the multifactorial falls prevention intervention, and (4) in long-term care residents, if multifactorial intervention cannot be conducted due to limited resources, the falls prevention strategy should still always include deprescribing of FRIDs.In the present statement paper, the working group on medication-related falls of the World Guidelines for Falls Prevention and Management, in collaboration with the European Geriatric Medicine Society (EuGMS) Task and Finish group on FRIDs, outlines its position on how to implement and execute these recommendations in clinical practice.Preferably, the medication review should be conducted as part of a comprehensive geriatric assessment to produce a personalized and patient-centered assessment. Furthermore, the major pitfall of the published intervention studies so far is the suboptimal implementation of medication review and deprescribing. For the future, it is important to focus on gaining which elements determine successful implementation and apply the concepts of implementation science to decrease the gap between research and practice.
老年人跌倒预防和管理是一项全球性的重大挑战。导致跌倒的一个关键风险因素是使用某些药物。因此,为了预防与药物相关的跌倒,近期的《世界跌倒预防与管理指南》中建议:(1)在开处方之前,评估跌倒史和跌倒风险,对有潜在增加跌倒风险的药物(FRIDs)进行评估;(2)在进行药物审查时,使用经过验证的结构化筛选和评估工具来识别 FRIDs;(3)将药物审查和 FRIDs 的适当减用纳入多因素跌倒预防干预措施的一部分;(4)在长期护理居民中,如果由于资源有限而无法进行多因素干预,那么跌倒预防策略仍应包括减少 FRIDs 的使用。在本立场文件中,《世界跌倒预防与管理指南》药物相关跌倒工作组与欧洲老年医学学会(EuGMS)FRIDs 工作组合作,概述了如何在临床实践中实施和执行这些建议的立场。最好将药物审查作为综合老年评估的一部分,以进行个性化和以患者为中心的评估。此外,迄今为止发表的干预研究的主要缺陷是药物审查和减药的实施不够完善。未来,重要的是要关注确定成功实施的要素,并应用实施科学的概念来缩小研究与实践之间的差距。